Global Information
회사소개 | 문의 | 비교리스트

전염병 관리를 촉진하는 신기술

Novel Technologies Driving Infectious Disease Management

리서치사 Frost & Sullivan
발행일 2019년 06월 상품 코드 883627
페이지 정보 영문 45 Pages
US $ 4,950 ₩ 6,199,000 Web Access (Regional License) help
리서치사의 웹사이트에 로그인할 수 있는 패스워드가 발급되며, PDF를 다운로드 받는 형태로 제공됩니다. 동일 국가 내에 있는 사업장의 모든 분들이 이용할 수 있는 라이선스이며, 이용 인원수 제한은 없습니다. 텍스트 등의 PDF 내용 편집은 불가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

전염병 관리를 촉진하는 신기술 Novel Technologies Driving Infectious Disease Management
발행일 : 2019년 06월 페이지 정보 : 영문 45 Pages

전염병 관리(Infectious Disease Management)를 전환하는 새로운 진단 기술 시장을 다루었으며, CRISPR 진단법, 면역측정법 및 비색분석법, 분자진단, 학제적 기술, 성장 기회 및 산업 영향요인 등에 대해 상세하게 분석했습니다.

제1장 주요 요약

제2장 기술 개요

  • 전염병 진단이 필요한 시점에서의 촉진요인 및 억제요인
  • 최근/새로운 전염병 동향 개요
  • 진단 기술 개요
  • 차세대 전염병 검사 : 세계

제3장 크리스퍼(CRISPR) 기반 신속 진단 기술 플랫폼

  • 모바일 접속형 CRISPR 기반 종이 진단 테스트
  • CRISPR와 전염병을 위한 합성생물학의 결합

제4장 전염병을 위한 면역측정법 및 비색분석법 업데이트

  • 무증후성 말라리아 원생동물 감염에 대한 타액을 이용한 신속 진단 검사
  • 5분 이내의 패혈증 초고속 진단
  • 5-in-1 모바일 접속형 소변검사
  • 관절염 진단을 위한 개량형 C6 펩티드 기반 ELISA

제5장 필요에 대응한 혁신적인 중합효소연쇄반응(PCR) 기술

  • 10분의 초신속 중합효소연쇄반응(PCR)
  • 병원체 특정을 위한 휴대용 실시간 PCR 플랫폼
  • 혈액 전염병용 3시간 이내 혈액 시퀀싱 결과, 기타

제6장 학제적 진단 플랫폼

  • 인공지능(AI), 컴퓨터 및 바이오인포매틱스에 근거한 진단 플랫폼
  • 전염병용 자기공명, PCR, 마이크로유체 및 NGP 기반 복합 방식
  • 전염병용 탄성표면파(SAW) 바이오센서
  • 다양한 진단 용도의 나노테크놀러지, 시퀀싱 및 바이오인포매틱스

제7장 성장 기회와 추천 행동(CTA)

  • 성장 기회 1 : 이상적인 POC 진단 검사
  • 성장 기회 2 : 분자진단
  • 성장 기회 3 : 학제적 접근
  • 성공 및 성장을 위한 전략적 원칙

제8장 주요 산업 영향요인

LSH 19.07.17

Upcoming Technologies for Infectious Disease Diagnosis

This research service covers emerging diagnostic technologies that can transform infectious disease management.

  • CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing CRISPR-based point-of-care (POC) rapid diagnostic tests which can be used with or without smartphone for detection of pathogens with improved precision.
  • Immunoassays and colorimetric tests: Immunoassays and colorimetric assays have been the most popular and conventional diagnostic tests used for rapid detection of infections. This research service shed light on some of the most recent advancements in immunoassays and colorimetric-based diagnostic tests for wide variety of infections, sepsis, malaria, Lyme Disease, and Urinary Tract Infections (UTIs).
  • Molecular Diagnostics: Polymerase chain reaction (PCR) has been proved to be the most accurate diagnostic test for genomic biomarker detection, however, its application in field as rapid diagnostic was hindered due to obvious limitations. New advancements in instruments, reagents (dry chemistry) and PCR technology are accelerating pathogen identification. This research service provide introduction to some of the most groundbreaking technologies in molecular diagnosis having great potential in field applications.
  • Multidisciplinary technologies: Developments in microfluidic technology, magnetic resonance, telecommunications, physics (surface acoustic waves) and many more are powering the exiting molecular diagnostics. Certain combinations are portrayed here.

Application of bioinformatics, artificial intelligence, and computational approaches: Next-generation sequencing (NGS) has revolutionized life sciences and healthcare. However, current laboratory-based approaches are still slow and time intensive. Advances in artificial intelligence (AI), computer programming, bioinformatics tools, and cloud technology have enabled generation of sophisticated databases. NGS along with these diverse approaches are transforming pathogen identification and provide more targeted and actionable treatments. Selected novel approached are described in this research service.

Nanopore Technology: New developments in nanotechnology are being applied to miniaturizing the devices for portable and field-based applications. Nanoscale lab-on-chip devices require minimum amount of biological sample. Nano devices are developed for NGS, detection of proteins and other biological analyte and have wide applications from clinical, agriculture to forensic and even space research. This research service summarizes two leading players and their nanopore technologies.

Table of Contents

1.0. Executive Summary

  • 1.1. Research Background: Innovating to Address the Diagnostic Gaps
  • 1.2. Research Scope: Emerging Infection Diagnostic Technologies
  • 1.3. Analysis Framework: Frost & Sullivan Core Value
  • 1.4. Research Methodology: Five Steps Toward Success
  • 1.5. Key Findings of Global Infection Diagnostic Technologies

2. Technology Snapshot

  • 2.1. Drivers and Challenges in Point of Need Infection Diagnostics
  • 2.2. Overview of Recent and Emerging Infection Diagnosis Trends
  • 2.3. Snapshot of Diagnostic Technologies
  • 2.4. Next Generation Infection Diagnostic Technologies, Global, 2019

3. CRISPR-based Rapid Diagnostic Technology Platforms

  • 3.1. Mobile Connected CRISPR-based Paper Diagnostic Tests
  • 3.2. CRISPR Combined With Synthetic Biology for Infection Diagnosis

4. Updated Immuno- and Colorimetric Assays for Infection Diagnosis

  • 4.1. Saliva-based Rapid Diagnosis Test for Subclinical Plasmodium Infections
  • 4.2. Ultra-rapid Diagnosis of Sepsis in 5 Minutes
  • 4.3. 5-in-1 Mobile Connected Urine Testing
  • 4.4. Improved C6 Peptide-based ELISA for Lyme Disease Diagnosis

5. Innovative Polymerase Chain Reaction Technologies for Point of Need Applications

  • 5.1. Ultrafast 10 Minute Polymerase Chain Reaction
  • 5.2. Portable Real-time PCR Platform for Pathogen Identification
  • 5.3. Blood-to-sequencing Results for Blood Infections Within 3 Hours
  • 5.4. Toehold Probe Multiplexed Platform for Infection Diagnosis
  • 5.5. Time Resolved Fluorescence Platform for Routine Pathogen Identification
  • 5.6. Partzymes-based Multiplex PCR for Multiple Pathogens Detection
  • 5.7. CoPrimersTM and RadioProbeTM Improve Specificity Of Diagnostic PCR

6. Multidisciplinary Diagnostic Platforms

  • 6.1. AI, Computational and Bioinformatics-based Diagnostic Platforms
  • 6.2. Magnetic Resonance, PCR, Microfluidics and NGP-based Combination Approaches for Infection Diagnosis
  • 6.3. Surface Acoustic Wave Biosensors for Infection Diagnosis
  • 6.4. Nanotechnology, Sequencing and Bioinformatics for Numerous Diagnostic Applications

7. Growth Opportunities and Companies to Action

  • 7.1. Growth Opportunity 1: Ideal Point of Care Rapid Diagnostic Test
  • 7.2. Growth Opportunity 2: Molecular Diagnostics
  • 7.3. Growth Opportunity 3: Multidisciplinary Approaches
  • 7.4. Strategic Imperatives for Success and Growth

8. Key Industry Influencers

  • 8.1. Industry Interactions-1
  • 8.2. Industry Interactions-2
  • Legal Disclaimer
Back to Top
전화 문의